File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/RLU.0000000000000252
- Scopus: eid_2-s2.0-85028106167
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Grover disease (Transient Acantholytic Dermatosis) in acute myeloid leukemia on FDG PET/CT
Title | Grover disease (Transient Acantholytic Dermatosis) in acute myeloid leukemia on FDG PET/CT |
---|---|
Authors | |
Issue Date | 2014 |
Citation | Clinical Nuclear Medicine, 2014, v. 39 n. 2, p. e173-e175 How to Cite? |
Abstract | A 48-year-old man with a newly diagnosed acute myeloid leukemia developed purpuric rash on day 6 after chemotherapy. Skin biopsy on day 8 demonstrated Grover disease. Triamcinolone treatment started on day 10 with subjective improvement on day 15. Initial FDG PET/CT on day 12 demonstrated rarely seen diffuse skin uptake that was interpreted as technical artifact and repeated on day 16. Accurately reviewing both PET and CT imaging would prevent confusion between diffuse cutaneous hypermetabolic activity and a technical artifact. Grover disease usually affects the trunk and may be related to the elimination of chemotherapy agents by sweating. |
Persistent Identifier | http://hdl.handle.net/10722/198768 |
ISSN | 2023 Impact Factor: 9.6 2023 SCImago Journal Rankings: 0.571 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhu, Hongyunjune | - |
dc.contributor.author | Clark, Lindsey N. | - |
dc.contributor.author | Deloney, Linda A. | - |
dc.contributor.author | McDonald, James E. | - |
dc.date.accessioned | 2014-07-09T03:42:13Z | - |
dc.date.available | 2014-07-09T03:42:13Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Clinical Nuclear Medicine, 2014, v. 39 n. 2, p. e173-e175 | - |
dc.identifier.issn | 0363-9762 | - |
dc.identifier.uri | http://hdl.handle.net/10722/198768 | - |
dc.description.abstract | A 48-year-old man with a newly diagnosed acute myeloid leukemia developed purpuric rash on day 6 after chemotherapy. Skin biopsy on day 8 demonstrated Grover disease. Triamcinolone treatment started on day 10 with subjective improvement on day 15. Initial FDG PET/CT on day 12 demonstrated rarely seen diffuse skin uptake that was interpreted as technical artifact and repeated on day 16. Accurately reviewing both PET and CT imaging would prevent confusion between diffuse cutaneous hypermetabolic activity and a technical artifact. Grover disease usually affects the trunk and may be related to the elimination of chemotherapy agents by sweating. | - |
dc.language | eng | - |
dc.relation.ispartof | Clinical Nuclear Medicine | - |
dc.title | Grover disease (Transient Acantholytic Dermatosis) in acute myeloid leukemia on FDG PET/CT | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1097/RLU.0000000000000252 | - |
dc.identifier.scopus | eid_2-s2.0-85028106167 | - |
dc.identifier.eissn | 1536-0229 | - |
dc.identifier.issnl | 0363-9762 | - |